Anna Rapacz

1.3k total citations
68 papers, 998 citations indexed

About

Anna Rapacz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Anna Rapacz has authored 68 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 33 papers in Cellular and Molecular Neuroscience and 26 papers in Organic Chemistry. Recurrent topics in Anna Rapacz's work include Neuroscience and Neuropharmacology Research (31 papers), Phenothiazines and Benzothiazines Synthesis and Activities (19 papers) and Epilepsy research and treatment (15 papers). Anna Rapacz is often cited by papers focused on Neuroscience and Neuropharmacology Research (31 papers), Phenothiazines and Benzothiazines Synthesis and Activities (19 papers) and Epilepsy research and treatment (15 papers). Anna Rapacz collaborates with scholars based in Poland, Germany and Norway. Anna Rapacz's co-authors include Barbara Filipek, Jolanta Obniska, Krzysztof Kamiński, Karolina Pytka, Henryk Marona, Jacek Sapa, Paweł Żmudzki, Anna M. Waszkielewicz, Agata Siwek and Adrian Olczyk and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Anna Rapacz

64 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Rapacz Poland	19	392	334	333	151	145	68	998
Hamed Shafaroodi Iran	22	345 0.9×	492 1.5×	370 1.1×	343 2.3×	214 1.5×	94	1.5k
Katarzyna Kulig Poland	19	382 1.0×	324 1.0×	312 0.9×	110 0.7×	90 0.6×	81	1.0k
Anna M. Waszkielewicz Poland	19	493 1.3×	302 0.9×	286 0.9×	191 1.3×	75 0.5×	80	1.2k
Andrzej Moniczewski Poland	12	455 1.2×	170 0.5×	149 0.4×	188 1.2×	77 0.5×	18	1.4k
Marta Andres‐Mach Poland	25	463 1.2×	653 2.0×	173 0.5×	277 1.8×	455 3.1×	76	1.5k
Cristiani Folharini Bortolatto Brazil	19	210 0.5×	195 0.6×	279 0.8×	131 0.9×	51 0.4×	73	1.0k
Estefanı́a Méndez-Álvarez Spain	26	664 1.7×	399 1.2×	480 1.4×	531 3.5×	69 0.5×	53	2.1k
César Augusto Brüning Brazil	24	251 0.6×	176 0.5×	315 0.9×	191 1.3×	57 0.4×	72	1.2k
Małgorzata Dybała Poland	18	195 0.5×	272 0.8×	176 0.5×	157 1.0×	42 0.3×	25	731
Alexander J. Stevens United Kingdom	16	247 0.6×	217 0.6×	86 0.3×	143 0.9×	77 0.5×	29	959

Countries citing papers authored by Anna Rapacz

Since Specialization

Citations

This map shows the geographic impact of Anna Rapacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rapacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rapacz more than expected).

Fields of papers citing papers by Anna Rapacz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rapacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rapacz. The network helps show where Anna Rapacz may publish in the future.

Co-authorship network of co-authors of Anna Rapacz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rapacz. A scholar is included among the top collaborators of Anna Rapacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rapacz. Anna Rapacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rapacz, Anna, Michał Abram, Jerry P. Jasinski, et al.. (2024). Discovery of New 3-(Benzo[b]Thiophen-2-yl)Pyrrolidine-2,5-Dione Derivatives as Potent Antiseizure and Antinociceptive Agents—In Vitro and In Vivo Evaluation. Pharmaceuticals. 17(11). 1532–1532.

Dziubina, Anna, et al.. (2022). Antinociceptive and Antiallodynic Activity of Some 3-(3-Methylthiophen-2-yl)pyrrolidine-2,5-dione Derivatives in Mouse Models of Tonic and Neuropathic Pain. International Journal of Molecular Sciences. 23(7). 4057–4057. 2 indexed citations

Czopek, Anna, Anna Rapacz, Anna Gębska, et al.. (2021). Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides. Molecules. 26(6). 1564–1564. 13 indexed citations

Abram, Michał, Anna Rapacz, Szczepan Mogilski, et al.. (2021). Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides. International Journal of Molecular Sciences. 22(23). 13092–13092. 3 indexed citations

Zaręba, Paula, Kinga Sałat, Georg Höfner, et al.. (2021). Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity. European Journal of Medicinal Chemistry. 221. 113512–113512. 11 indexed citations

Abram, Michał, Anna Rapacz, Szczepan Mogilski, et al.. (2020). Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents. ACS Chemical Neuroscience. 11(13). 1996–2008. 17 indexed citations

Kamiński, Krzysztof, Szczepan Mogilski, Michał Abram, et al.. (2020). KA‐104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models. Epilepsia. 61(10). 2119–2128. 11 indexed citations

Abram, Michał, Anna Rapacz, Szczepan Mogilski, et al.. (2020). The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure—Synthesis and In Vivo/In Vitro Studies. International Journal of Molecular Sciences. 21(22). 8780–8780. 4 indexed citations

Obniska, Jolanta, et al.. (2020). Synthesis, anticonvulsant, and antinociceptive activity of new 3‐(3‐methyl‐2,5‐dioxo‐3‐phenylpyrrolidin‐1‐yl)propanamides and 3‐phenyl‐butanamides. Archiv der Pharmazie. 354(1). e2000225–e2000225. 6 indexed citations

10.

Kubacka, Monika, Anna Rapacz, Kinga Sałat, et al.. (2020). KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies. European Journal of Pharmacology. 886. 173540–173540. 6 indexed citations

11.

Zaręba, Paula, Kinga Sałat, Georg Höfner, et al.. (2019). Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice. European Journal of Medicinal Chemistry. 188. 111920–111920. 13 indexed citations

12.

Czopek, Anna, et al.. (2019). Synthesis and pharmacological evaluation of novel N-Mannich bases derived from 5,5-diphenyl and 5,5-di(propan-2-yl)imidazolidine-2,4-dione core. Bioorganic & Medicinal Chemistry Letters. 29(16). 2387–2392. 7 indexed citations

13.

Rapacz, Anna, Monika Głuch‐Lutwin, Barbara Mordyl, et al.. (2018). Evaluation of anticonvulsant and analgesic activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and –butanamides. Epilepsy Research. 143. 11–19. 13 indexed citations

14.

Obniska, Jolanta, et al.. (2017). Synthesis and Anticonvulsant Properties of New 3,3‐Diphenyl‐2,5‐dioxo‐pyrrolidin‐1‐yl‐acetamides and 3,3‐Diphenyl‐propionamides. Archiv der Pharmazie. 350(3-4). 8 indexed citations

15.

Pytka, Karolina, Katarzyna Socała, Anna Rapacz, et al.. (2017). HBK-14 and HBK-15, triple 5-HT 1A , 5-HT 7 and 5-HT 3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 79(Pt B). 378–385. 14 indexed citations

16.

Gunia‐Krzyżak, Agnieszka, Dorota Żelaszczyk, Anna Rapacz, et al.. (2016). Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3. Bioorganic & Medicinal Chemistry. 25(2). 471–482. 18 indexed citations

17.

Kamiński, Krzysztof, Mirosław Zagaja, Anna Rapacz, et al.. (2015). New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones. Bioorganic & Medicinal Chemistry. 24(4). 606–618. 21 indexed citations

18.

Rapacz, Anna, et al.. (2015). Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(3). 339–348. 19 indexed citations

19.

Sałat, Kinga, Tadeusz Librowski, Joanna Gdula‐Argasińska, et al.. (2012). Influence of Gamma-Butyrolactone Derivatives with Analgesic Properties on the Prostaglandin E2 Level and Gastric Mucosa in Rodents. Acta Biologica Cracoviensia. Series Zoologia. 53(54). 1 indexed citations

20.

Rapacz, Anna, Karolina Pytka, Magdalena Dudek, et al.. (2011). Effect of new xanthone derivatives on the level of endogenous nitric oxide in some tissue homogenates in rats. Jagiellonian University Repository (Jagiellonian University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact